Fresenius Medical Care AG (XTER:FME) EPS (Basic): €3.28 (TTM As of Mar. 2026)


XTER:FME Fresenius Medical Care AG XTER:FME
70 GF Score
Price €41.55
GF Value €41.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG EPS (Basic)?

Fresenius Medical Care AG XTER:FME +0.73% 70 EPS (Basic) is €3.28 as of Mar. 2026. GuruFocus rates XTER:FME with a GF Score™ of 70/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 4 warning signs investors should review.

Fresenius Medical Care AG's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.43. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.28.

Fresenius Medical Care AG's EPS (Diluted) for the three months ended in Mar. 2026 was €0.43. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.28.

Fresenius Medical Care AG's EPS without NRI for the three months ended in Mar. 2026 was €0.81. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.89.

During the past 12 months, Fresenius Medical Care AG's average EPS without NRIGrowth Rate was 56.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was -3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fresenius Medical Care AG's highest 3-Year average EPS without NRI Growth Rate was 165.70% per year. The lowest was -17.10% per year. And the median was 8.55% per year.

Fresenius Medical Care AG  (XTER:FME) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fresenius Medical Care AG EPS (Basic) Related Terms

Fresenius Medical Care AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG EPS (Basic) Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.31 2.30 1.70 1.83 3.36

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.77 0.94 1.14 0.43
XTER:FME
70GF Score
Fresenius Medical Care AG XTER:FME
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fresenius Medical Care AG's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(978.367-0)/291.191
=3.36

Fresenius Medical Care AG's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(117.529-0)/275.246
=0.43

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €3.28 mean?
Fresenius Medical Care AG (XTER:FME) has a EPS (Basic) of €3.28 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's EPS (Basic) too high?
Fresenius Medical Care AG's current EPS (Basic) is €3.28. Overall, Fresenius Medical Care AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's EPS (Basic) compare to HCA and THC?
Fresenius Medical Care AG's EPS (Basic) of €3.28 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current EPS (Basic) is €3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €41.55 — trading 0.6% above its estimated fair value. The current EPS (Basic) is €3.28. Fresenius Medical Care AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current EPS (Basic) is €3.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of €41.55 is trading 0.6% above its estimated GF Value™ of €41.29. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for XTER:FME:

  • EPS (Basic): €3.28
  • GF Value™: €41.29 vs. price of €41.55 (0.6% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
70GF Score

Get the complete analysis for XTER:FME

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.55
Price
€41.29
GF Value